On Pandemic Alert, Regulators See ‘Yellow Flags’ In Immunity Claims For Supplements
Executive Summary
Supplement immunity claims are more likely to get regulators’ attention when they also explain immunity’s importance, often moving into treatment claims, says attorney Justin Prochnow. Hash tags mentioning COVID-19 or staying healthy during the pandemic also can suggest products treat the virus.
You may also be interested in...
Like Consumer Health Ad Claims About COVID-19, Customer Testimonials Are False And Misleading
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.
No Enforcement Immunity For Testimonials On Immunity Or Claims With 'Alert: No COVID-19 Cure'
Elderberry syrup marketer Provezza Health targeted review of claims consumers may link to COVID-19 prevention or treatment due to testimonials not dispelled by the firm. FDA and FTC warn CBD firm to discontinue claims noting immunity-boosting is the “best defense” against COVID-19.
False COVID-19 Claims In US Consumer Health Market: Rampant With Forecast For More
In addition to 45 businesses with varying levels of communication skills the FTC targeted in its latest batch of warnings about false advertising linked coronavirus, the FDA "sent hundreds of abuse complaints to domain name registrars and internet marketplaces" also linked to bogus COVID-19 claims.